-
OxyContin Maker Purdue Pharma Pleads Guilty in Criminal Case
Purdue Pharma says its guilty plea over its role in the opioid crisis is “an essential step to preserve billions of dollars” for the settlement it is pursuing in bankruptcy court
-
Purdue Pharma Pleads Guilty for Role in Opioid Crisis
Purdue Pharma, the manufacturer of the painkiller Oxycontin, pleaded guilty to charges for its role in the opioid crisis.
-
CVS Subsidiary to Pay $15.3M Over Opioid Allegations, Prosecutors Say
Omnicare Inc., a subsidiary of CVS Health and a provider of pharmacy services to long-term care facilities, agreed to pay a $15.3 million penalty to resolve allegations that it allowed opioids to be dispensed without prescriptions, federal prosecutors in Los Angeles announced Wednesday. The Cincinnati-based Omnicare operates non-public “closed door” pharmacies that deliver controlled substances to nursing homes and other…
-
Kenney Warns of Deaths as Safe Injection Site Plan Gets Scrapped
In his first public remarks since plans to open a supervised injection site in South Philadelphia were scrapped, Mayor Jim Kenney warned that people could die as a result.
-
Philly's Mayor Is Not Happy About Supervised-Injection Site Rejection
Mayor Jim Kenney says he is disappointed that an overdose prevention site in South Philadelphia was denied by residents. NBC10’s Stephania Jimenez reports on the harsh words Kenney had for critics of the supervised-injection site.
-
Supervised Injection Site No Longer Opening at South Philly Plaza
Constitution Health Plaza, expected to be the first location in the United States for a supervised injection site, said they have canceled plans to allow for the Safehouse facility.
-
U.S. Attorney Warns of ‘Street Fight' in Supervised Injection Site Battle
The U.S. Attorney for the district covering Philadelphia is warning about the potential for a “literal street fight” as he seeks to halt the opening of a supervised injection site in the city.
-
Supervised Injection Site Won't Be in South Philadelphia
The nation’s first supervised injection site for drug users will not be in South Philadelphia after all, NBC10 reporter Drew Smith found. What happened in a day that changed history?
-
What Is a Supervised Injection Site?
Philadelphia is the first place in the country to open a supervised injection site. NBC10’s Mitch Blacher tells us all we need to know about the facility in South Philly that will allow drug users to inject opioids.
-
South Philly Residents Express Anger Over 1st Supervised Injection Site in U.S.
People living in South Philadelphia had no clue that the first supervised injection site would be right in their neighborhood. There will be no handle or selling of the drugs, the users have to bring their own. But they will give clean needles, supervision, and social workers who will be actively offering treatment.
-
Reaction to South Philly Supervised Injection Site
South Philadelphia residents are opposed of a supervised injection site that has been placed in the neighborhood. NBC10 reporter Randy Gyllenhaal reports.
-
US Attorney Announces $145M Settlement in Opioid Case
Federal prosecutors in Vermont say a health information technology company will pay $145 million to resolve criminal and civil charges that it helped set up an electronic health records system that encouraged physicians to prescribe opioids to people who might not need them
-
Ex-Drug Company Execs Face Reckoning in Opioid Bribery Case
The founder and former top employees of a pharmaceutical company are being sentenced in a bribery scheme that prosecutors say helped fuel the national opioid epidemic. Starting Monday, seven people who worked for Insys Therapeutics will appear in Boston federal court for their sentencing. The case against company founder John Kapoor and his associates was considered the first to hold...
-
States Tackle Big Issues With New Laws, Including Data Privacy, Voting
Owners of electric vehicles in a number of states will start seeing fees to pay for road repairs in the new year. At least eight states will begin charging new or higher registration fees Wednesday for electric vehicles or plug-in hybrids. The new fees mean that, for the first time, a majority of states will assess special fees on gas-free...
-
4-Day Sting Takes $670,000 in Drugs, High-Powered Guns Off Philly Streets
A narcotics operation in the Kensington and Fairhill neighborhoods netted 200 arrests and took 21 guns and around $670,000 worth of drugs off the streets, police say.
-
MLB, Union Agree to Testing for Opioids After Skaggs' Death
Major League Baseball will start testing for opioids and cocaine. But only players who do not cooperate with their treatment plans will be subject to discipline. Marijuana will be removed from the list of drugs of abuse and will be treated the same as alcohol as part of changes to the joint drug agreement between MLB and the players’ association....
-
MLB, Union Agree to Begin Opioid Testing
Major League Baseball and the Major League Baseball Players Association agreed to begin testing for opioids, cocaine, fentanyl and synthetic THC. They will also remove marijuana from the list of drugs of abuse.
-
Testing, No Suspensions for Opioids Considered Likely in MLB
Players who test positive for opioids would enter treatment and not be suspended under the change to Major League Baseball’s drug agreement being negotiated by management and the players’ association, according to union head Tony Clark. Talks to add testing for opioids began following the death this year of Los Angeles Angels pitcher Tyler Skaggs. Players have been tested...
-
Drug Dealers Nabbed While Trying to Sell to Students in Philadelphia
Authorities say three drugs dealers who attempted to sell narcotics to school students in Philadelphia have been arrested.
-
Amid Opioid Crisis, Study Sees Large Gaps in Access to Naloxone in Philadelphia
An opioid overdose antidote spray was not in stock in most Philadelphia pharmacies during a 2017 survey, and the shortage was greatest in predominantly minority neighborhoods and areas with the most fatal opioid overdoses, according to a study released Friday.